Christine H. Holschneider, MD
Languages
Institutional Affiliation
Education
Fellowship
Degree
Residency
Board Certifications
Contact Information
Phone
Scientific Interests
Dr. Christine Holschneider's research focuses on the molecular pathogenesis of human papillomavirus (HPV)-associated intraepithelial neoplasia and carcinoma of the lower genital tract.
Highlighted Publications
Beavis AL, Cheema S, Holschneider CH, Duffy EL, Amneus MW. Almost half of women with endometrial cancer or hyperplasia do not know that obesity affects their cancer risk. Gynecol Oncol Rep. 2015 Jul 8;13:71-5. doi: 10.1016/j.gore.2015.07.002. eCollection 2015.
Saleeby E, Holschneider CH, Singhal R. Paradigm shifts: using a participatory leadership process to redesign health systems. Curr Opin Obstet Gynecol. 2014 Dec;26(6):516-22. doi: 10.1097/GCO.0000000000000122.
Beavis A, Amneus M, Aoyama C, Holschneider CH. Tattoo pigment lymphadenopathy mimicking metastasis in vulvar cancer. Obstet Gynecol. 2012 Aug;120(2 Pt 2):442-4. doi: 10.1097/AOG.0b013e3182583be2.
Penner KR, Dorigo O, Aoyama C, Ostrzega N, Balzer BL, Rao J, Walsh CS, Cass I, Holschneider CH. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy. Gynecol Oncol. 2012 Mar;124(3):542-8. doi: 10.1016/j.ygyno.2011.11.004. Epub 2011 Nov 10.
Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE, Goff BA. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011 Jun;204(6):466-78. doi: 10.1016/j.ajog.2011.03.008.